End of #ebmt24 - thank you all for a lovely 50th anniversary celebration.
⁦The EBMT⁩

📢Join us for the upcoming post The EBMT webinar!

Round Table Debate Dedicated to the Hottest Findings from EBMT 2024

🗓️April 23 2024
⏲️6PM CET, 12PM NY

Register for FREE👇
bit.ly/3Wksl8f

Bipin Savani Florent Malard Arnon Nagler Mohamad Mohty

Proud to see Pr. Mohamad Mohty highlighting the potential of the modulation of the gut microbiota to improve survival for patients resistant to ruxolitinib and corticosteroids ! #EBMT24 #GVHD

Always a pleasure to hear from Mohamad Mohty, who shared some insights into the treatment & management of steroid-refractory #GvHD & updates on the management of VOD!

#EBMT24 has been filled with some wonderful content & we're excited to share these interviews!

The EBMT #BMTsm

The registry is the key asset of ⁦The EBMT⁩ This registry is likely the oldest one in Europe.
Please joins us this morning for a timely session discussing the importance and added-value of real-world evidence to advance therapy and care of patients. #ebmt24 ⁦IACH⁩

Looking forward to Chair the Oral Session 15 The EBMT, Predicting and Managing HSCT complications, starting 1230 today and see some fantastic presentations on Final day of the congress..

come join #EBMT24 Nico Gagelmann Mohamad Mohty vp Antonio Pagliuca

Outstanding presentation by Corey Cutler at #EBMT24 on belumosudil for chronic GvHD (ROCKstar study)

After 3 years' follow-up, the larger study population behaved similarly to the population at 1 year and continued to have a good response to belumosudil with no new safety concern

The registry is the key asset of ⁦The EBMT⁩ This registry is likely the oldest one in Europe.
Please joins us this morning for a timely session discussing the importance and added-value of real-world evidence to advance therapy and care of patients. #ebmt24 ⁦IACH⁩

Great session about progress in GHVD prophylaxis and treatment #EBMT24 Mohamad Mohty

The newly elected Lymphoma Working Party Chair at EBMT is Dr. Ali Bazarbachi American University of Beirut American University of Beirut Medical Center Ali Abu-Alfa Dr. Fadlo Khuri #EBMT24

#EBMT24
Outstanding presentation by Dr. Yishan Ye on the behalf of the ALWP of The EBMT.

For CBF-AML patients in CR2, haploidentical HCTs were associated with a lower RI compared to MSD and MUD allo-HCTs, leading to similar LFS, OS and GRFS.

Mohamad Mohty

CONGRESS #EBMT24 | Yishan Ye, Zhejiang University School of Medicine discusses an EBMT registry-based analysis of outcomes following allo-HCT using either HAPLO, MSD, or MUD. HAPLO was associated with a higher 2-year NRM. The 180-day CI of grade II-IV aGVHD was higher in…

Lower dose PT-Cy with ATG for GVHD prophylaxis #EBMT24 Mohamad Mohty

Another great lecture by Mohamad Mohty The EBMT #ebmt24 at the educational session of ALWP. GvHD Prophylaxis. A lot going on. Outcomes are improving. “PTCY has come to stay…”

Congratulations The EBMT for 50 years of supporting and growing the international transplant and cellular therapy community #EBMT24

ALWP session #EBMT24 Mohamad Mohty

While gearing up for the 3rd day of #EBMT24 , special kudos to ⁦Anna Sureda⁩ , ⁦The EBMT⁩ teams, the local organizers, et al.
Despite the cold and rainy weather, one can sense the warm hospitality and the shining scientific content. Happy 50th anniversary.

Please join us this morning in the CLYDE room for this session dedicated to the latest advances in acute leukemia. #ebmt24

Good morning ☀️☕, and welcome to the third day of the 50th Annual Meeting of the EBMT! 👏

Check your email for the daily #EBMT24 Newsletter and don't miss today's highlights! View the programme covering 🔑 key sessions, a recap from yesterday and more ⬇️
ebmt2024.abstractserver.com/program/#/prog…

While gearing up for the 3rd day of #EBMT24 , special kudos to ⁦Anna Sureda⁩ , ⁦The EBMT⁩ teams, the local organizers, et al.
Despite the cold and rainy weather, one can sense the warm hospitality and the shining scientific content. Happy 50th anniversary.